Psychoneuroimmunology: application to ocular diseases by Ventura, Lori M.
ERRATUM
Psychoneuroimmunology: application to ocular diseases
Lori M. Ventura
Published online: 19 September 2009
# The Author(s) 2009. This article is published with open access at Springerlink.com
Erratum to: j ocul biol dis inform
DOI 10.1007/s12177-009-9028-4
The following article was mistakenly run in volume 2, issue
2 (June 2009) instead of in the present special issue, for
which it was intended. The publisher regrets the error.
Please also note additional author corrections as follows: on
third page of the article, in the first paragraph under
“Potential pathophysiological mechanisms,” where was
written cortisol release hormone (CRH)” now reads “Corti-
cotrophin Releasing Hormone (CRH).” On the seventh page
of the article, where was written “25-h” now reads “24-h.”
Abstract Psychoneuroimmunology (PNI) is a relatively new
discipline within the field of neuroscience which researches
the relationship between emotional states, the central and
peripheral nervous systems, and the endocrine and immune
systems. Negative psychological states, such as stress,
anxiety, and depression, may alter immune system regulation
and modulation of peripheral cytokines. A plethora of PNI
studies have shown that increased psychological stress and
depression are associated with an alteration of immune
functioning and worsened health outcomes for many con-
ditions.To date, application ofPNI methodology has not been
reported for ocular diseases. This article provides an historical
perspective on the origins of the rift between the emotional
and spiritual from physical aspects of disease. A review of
how stress is mediated through sympathetic adrenomedullary
and hypothalamic pituitary axis activation with shifts in
immunity is provided. The literature which supports spiritu-
ality in healing is presented. Finally, ocular diseases which
would be most amenable to a PNI approach are discussed.
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Glaucoma.Maculardegeneration.Centralserous
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The connection of mind, body, and spirit
Many ancient cultures felt a connection between mind,
body, and spirit. Illness has often been associated with sin
[1, 2], and some societies sensed that healing could be
restored by remaining in favor with the divine through an
exorcism of evil spirits. The healing practice of shamanism
is thought to have had its origins in Siberia dating as far
back as 20,000 years ago. Shaman healers serve as
mediaries between the spiritual and physical world. Once
possibly universal, shamanism survives today primarily
among indigenous peoples, and is especially widespread in
Africa, Asia, and South America. As the practice of
medicine evolved, the most insightful physicians clung to
the belief that illness did not originate exclusively from that
which is physical. Hippocrates in 400B.C.E. stated: “I would
rather know what sort of person has a disease than what
sort of disease a person has.” Ibn Sina, known by the
Europeans as Avicenna, a Persian physician, philosopher,
and scientist born in 980CE, was fascinated by the effect of
the mind on the body, and wrote a great deal on psychology.
Hismostfamousworks,The Book of Healing and The Canon
of Medicine, served as textbooks of medicine in Europe for
the next 500 years. His feeling was that the evaluation of a
“disease” was incomplete until and unless all components of
ap e r s o n ’s life had been included in the diagnosis.
Clinical medicine of the modern Western world has
certainly eliminated the spiritual and, for the most part, the
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authority to their doctors who must take on the magnani-
mous role as healer. Beinfield and Korngold [3] in their
book Between Heaven and Earth wrote “As the breadth and
depth of scientific information about the body grew, doctors
and patients lost faith in the capacity of the human
organism to heal itself. People mistakenly feel that the
power to cure comes exclusively from outside them-
selves…administered by an alien intelligence.” The doctor
becomes the exclusive source of specialized knowledge,
and is either the heroic slayer of disease, when their
applications and surgical interventions have favorable out-
comes, or are demonized for medication or surgical failures.
Imbued as deity, physicians of today infrequently recognize
a need for pastoral or psychiatry consults for our patients.
A brief historical review explains how this schism occurred.
The schism of mind, body, and spirit
Until the Renaissance (1350), people were made to feel that
theyhadtogooutsidethemselvesforsalvation.Theclergywere
the sole interpreters of the scripture, the sole mediators between
God and man, and the sole arbitrators of one’s salvation.
By the 1500s, a breach of faith caused people to become
less dependent on the spiritual community of the church.
During the Renaissance, there was a shift in focus from the
spiritual to the acquisition of knowledge as religion was
overshadowed by science, and the clergy lost their
popularity to the mathematicians, the physicists, and the
engineers. Science set itself out to explain everything
including the nature of God, but when science could not
explain God, a lack of security developed in Western
culture, and man lost his spiritual footing. By the 17th
century, Descartes declared, “There is nothing in the
concept of body that belongs to the mind, and nothing in
that of mind that belongs to the body.” With this statement,
Descartes chiseled a schism between the mind and the body,
and dualism shattered the unity of mind, body, and spirit.
Re-establishing the link of mind and body
Despite this schism, a few insightful minds clung to the
unity of ages past. Sir William Osler at the turn of the 20th
century wrote, “The outcome of tuberculosis has more to do
with the state of a patient’s mind than the state of his
lungs.” It took 300 years for the seminal work of Ader and
Cohen [4] to create a line of research known as psycho-
neuroimmunology which scientifically reestablished a link
between emotions and disease.
Psychoneuroimmunology (PNI) is a relatively new
discipline within the field of neuroscience which has its
origins from the work of Ader and Cohen in the 1970s. PNI
researches the relationship between emotional states, the
central and peripheral nervous systems, and the endocrine
and immune systems. Negative psychological states, such
as stress, anxiety, and depression, may alter immune system
regulation and modulation of peripheral cytokines. A
plethora of PNI studies have shown that increased
psychological stress and depression are associated with a
decrease in immune functioning and worsened health
outcomes for many conditions including coronary artery
disease [5], cancer [6], autoimmune disease [7, 8], infection
[9, 10], wound healing [11], and even Alzheimer’s disease
[12]. The literature is replete with examples for each of
these conditions. For example, Kaprio et al. [13] showed
that, in 95,647 widowed persons, the significant psycho-
logical stressor of loss of a spouse increases all-cause
mortality. Breast cancer patients who are prone to stress
have flattening of their diurnal cortisol slopes which has
been associated with shorter survival times and greater
progression [14]. The British Common Cold Study [15]
showed that subjects with more stress had higher incidence
of colds. Subsequently in 1998, the Pittsburgh Common
Cold Study [16] showed that chronic interpersonal stressors
such as conflicts with friends, family, or spouses and work
problems related to unemployment or underemployment
place individuals at greater risk for upper respiratory
infection. Furthermore, there was a linear increase in the
risk for illness with increasing duration of the stressor, and
patients with greater perceived stress had worse cold
symptoms and higher IL-6 levels. Poorer sleep efficiency
and shorter sleep duration in the weeks preceding exposure
to a rhinovirus were associated with lower resistance to
illness [17].
From research on coping styles, it appears that the
manner of responding to stressful events has implications
both psychologically and physiologically [18]. Just as
negative states have been cited to be associated with poorer
outcomes, positive coping strategies have been correlated
with more favorable health outcomes. For example, Carver
[19] published that “finding benefit” among women with
breast cancer during the year after diagnosis predicts better
adjustment 5 to 8 years after diagnosis. Similarly in 2005,
he published that an optimistic personality and psychoso-
cial well-being during treatment predict psychosocial well-
being among long-term survivors of breast cancer. A study
by Penedo et al. [20] in men treated for localized prostate
cancer suggests that optimism is associated with natural
killer cell cytotoxicity and with a greater ability to adaptively
express anger. In this group, it appears that less anger
suppression partially mediates the relationship between
optimism and natural killer cell cytotoxicity. Gonzalez et
al. [21] conducted a cross-sectional study of HIV-positive
men and women on highly active antiretroviral therapy, and
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mind related to better medication adherence, whereas
higher depression scores related to non-adherence. The
authors concluded that positive states of mind may be an
important mechanism through which social support is
related to better medication adherence in this population.
Similarly, Ickovics et al. [22] showed that psychological
resources in HIV-seropositive women, such as finding
meaning in challenging circumstances and positive affect,
may protect against HIV-related mortality and immune
system decline.
Negative emotional states are as detrimental to the
central nervous system as to the immune and other organ
systems. Sheline et al. in 2003 showed that chronic
depression leads to neuronal cell loss in the hippocampus
[23]. Later, in 2006, Ownby et al. [12] concluded that a
history of depression may confer an increased risk for later
developing Alzheimer’s disease, and that this relation may
reflect an independent risk factor for the disease. If chronic
depression leads to hippocampal volume loss, then negative
emotional states may also be associated with deterioration
of other areas of the central nervous system such as ocular
structures. Patients who show onset or progression of
ocular disease may acknowledge heightened emotional
stress, yet among ophthalmologists, such a relationship
has only been recognized for central serous retinopathy and
reactivation of herpetic infection. There are three mecha-
nisms by which negative emotional states or psychological
stress may mediate injury to ocular structures, and
potentially susceptible ophthalmic diseases are discussed.
Potential pathophysiological mechanisms
of psychological stress
The first mechanism by which stress may cause injury to
the eye is through diminished microvascular perfusion
through sympathetic nervous system overdrive. Stressful
stimuli may first be perceived visually or auditorily, or may
be triggered by emotional signaling at the pre-frontal
cortex. Whatever the origin of the stressor, there is
signaling to the hippocampus for an interpretation based
on memory. From the hippocampus, stimuli which evoke a
fear response will synapse with neurons in the amygdala
sending efferent projections to the paraventricular nucleus
(PVN) of the hypothalamus which secretes corticotropin-
releasing hormone (CRH) and arginine vasopressin (AVP)
[11]. In addition to an antidiuretic effect, AVP increases
peripheral vascular resistance to increase arterial blood
pressure. Corticotropin-releasing hormone (CRH) travels in
the hypothalamo-hypophyseal portal circulation to the
pituitary (perhaps within 10 s) to stimulate the release of
ACTH, enkephalins, and endorphins [11, 24]. In addition to
regulation of ACTH release, CRH flows diffusely throughout
the brain, and serves as a neurotransmitter that mediates
sympathetic arousal, providing an important link between the
adrenocortical and autonomic branches of the stress response
[24]. Noradrenergic centers in the brainstem (locus coeru-
leus) and spinal cord activate the sympathetic adrenomedul-
lary (SAM) release of epinephrine from the adrenal medulla
and norepinephrine from the peripheral autonomic nervous
system. CRH and noradrenergic neurons in the CNS
innervate and stimulate each other [11]. Acutely, the
immediate response to psychological stress is activation of
SAM, with vasoconstriction of blood vessels which may be
narrowed to varying degrees from years of arteriolosclerosis.
Stress-induced vasospasm may compromise perfusion of
the microvascular beds of the circulatory system, thereby
inducing hypoxia, which may acutely exacerbate a number
of ocular disease states including arteriolar obstructive
phenomena, ischemic optic neuropathy, venous occlusive
disease, and ischemic palsy of the cranial nerves. Initial
ischemic insult with a sudden vaso-occlusive event or the
subsequent reperfusion injury may induce damage. Chronic
psychological stressors with ongoing activation of SAM
result in vasoconstriction which may be prolonged, and
may lead to hypertension and subsequent progression of
arteriolosclerosis. Ocular conditions which may theoretical-
ly be exacerbated by chronic psychological stress would be
any of the microvascular diseases such as hypertensive
retinopathy, diabetic retinopathy, etc.
The second potential mechanism of how stress may
exacerbate ocular disease is through the overdrive of the
hypothalamic pituitary axis (HPA). The complexities of
stressor-induced activation of the HPA and SAM (also
known as sympathetic nervous system—SNS) have been
comprehensively reviewed in other publications [25–27],
and an abbreviated summary of the neural pathways
provoked by stressors is provided here. Acutely stressful
stimuli activate SAM as well as neurons of the hypothal-
amus to produce Corticotrophin Releasing Hormone
(CRH). CRH-containing neurons stimulate the pituitary to
release ACTH, endorphins, and enkephalins into the
bloodstream [11]. ACTH then stimulates the release of
cortisol from the adrenal cortex. The HPA response to stress
is not as immediate as SAM, but occurs within minutes
[24]. Under normal non-stressed conditions, cortisol levels
peak in the early morning hours, fall over the course of the
day, in a fairly steep slope, to reach a low around 4PM, and
remain low throughout the night only to peak again in the
morning, and this is known as the diurnal fluctuation.
Chronic psychological stress has been shown to elevate
cortisol levels to induce a flattening of the diurnal cortisol
slope [14]. Such chronic cortisol elevation is associated
with worsening outcomes in breast [14] and ovarian cancer
[28], and may have deleterious effects on ocular diseases
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between chronic stress and central serous chorioretinopathy
(CSR), since CSR is known to occur in Cushing’s disease
with endogenous cortisol excess [29]. Ocular hypertension
and glaucoma also occur in endogenous Cushing’s disease
[30].
The third potential mechanism of how stress may
exacerbate ocular disease is through alteration of the
immune profile. As mentioned, under psychologically
stressful conditions, CRH and noradrenergic neurons in
the CNS innervate and stimulate each other. Moynihan
describes that activation of SAM and the HPA may have
profound and complex downstream effects on immune
function. Of the four categories of hormones that may
change with stress (catecholamines, CRH, endogenous
opioids, and glucocorticoids), cortisol has received the
greatest attention as the potential mediator of stress-induced
changes in immunity [31]. The effects of stress on
immunity are not unidirectional, and may vary based on
three broad categories of variables: the experimental subject
(age, sex, and strain), the nature of the stressor (intensity,
duration, and perception), and the immune parameter
examined (T helper 1 vs. T helper 2) [31]. For example,
activation of the sympathetic nervous system primarily
inhibits the activity of cells associated with the innate
immune system, while it either enhances or inhibits the
activity of cells associated with the acquired/adaptive
immune system [32]. Whether the stressor is acute or
chronic may alter the quality of the immune response
dramatically. While acute stressors may enhance or sup-
press various facets of the immune response, chronic
psychological stressors appear to be most often associated
with suppressed immune function [31]. Chronic stress is
associated with dysregulation in the negative feedback
control of CRH–ACTH–cortisol loop resulting in chronic
elevation of cortisol in the circulation [14].
Both aging and chronic stress may induce shifts in the
immune system. Immune responses are regulated by
antigen-presenting cells (APC) such as monocytes/macro-
phages, dendritic cells, microglia, and other phagocytic
cells which are the components of innate immunity.
Adaptive immune responses are mediated by T regulatory
lymphocytes, T helper 1 cells (Th1) which promote cellular
immunity, and T helper 2 cells (Th2) which enhance
humoral immunity [11, 33]. Th1 effects are mediated by
cytokines interferon-γ, interleukin-2, interleukin-12,
interleukin-18, TNF-α, and T cells and macrophages. Th2
responses are mediated through the secretion of a different
set of cytokines, primarily interleukin-1, interleukin-4,
interleukin-6, interleukin-10, and interleukin-13, and B
cells, eosinophils, and mast cells [11]. With aging, there is
an involution of the thymus gland. Although not conclu-
sive, most studies seem to suggest that aging is associated
with a shift from a Th-1-dominated, cell-mediated immune
response to a Th2 non-specific humoral response [33].
Chronic psychological stressors may induce a similar shift
in immunity. Glucocorticoids and catecholamines mediate a
Th2 shift by up-regulating Th2 cytokine production and
also by suppressing APCs and Th1 cytokine synthesis [34,
35]. Through the above mechanisms, stress may influence
the onset and/or course of infectious, autoimmune/inflam-
matory, allergic, and neoplastic diseases [35].
It should be noted that the nervous and immune systems
are tightly connected. Tausk et al. [11] review the evidence
for this as follows. First, CNS (hypothalamic) interventions
(including lesioning studies) alter immunologic reactivity,
and the elicitation of an immune response alters CNS
activity. Second, there is sympathetic innervation of spleen
and other lymphoid organs, including the skin [32]. Third,
changes in hormone or transmitter levels produce changes
in immune function and vice versa. Finally, lymphoid cells
express receptors for a variety of hormones and transmitters
[32]. Thus, lymphoid cells are exposed to neurochemical
ligands, and express the receptors necessary to bind them.
Tausk et al. further elaborate that the communication
between the brain and immune system is bidirectional,
with signaling back to the brain via the vagus nerve, and
via soluble cytokines, including interleukin (IL)-6, IL-1,
and tumor necrosis factor (TNF)-α [11, 36, 37].
Diseases potentially susceptible to psychological stress
Glaucoma
Stress and vasospasm in glaucoma
Retinal ganglion cells (RGCs) as one of the most
metabolically active cells of the body have high numbers
of mitochondria. Mitochondria play an important role in
energy (ATP) production through the oxidative phosphor-
ylation pathway and the regulation of cell death by
apoptosis [38]. Mitochondria are particularly abundant
along the unmyelinated intraretinal axons of the RGCs to
supply energy in high demand for electrical conduction and
axonal transport [39]. A steady supply of oxygen is
necessary for oxidative phosphorylation to generate ATP.
The microvascular supply of oxygen to RGC axons may
deteriorate with aging as progressive arteriolosclerosis may
result in vascular compromise of the inner retinal circula-
tion. There is a natural loss of RGCs with aging in the
normal population [40]. Several risk factors for glaucoma
have been identified, some of which are strong including
high intraocular pressure, increasing aging, family history
of glaucoma, Black race, and other possible risk factors
including high myopia, hypertension, diabetes, migraine
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vascular insult to an already compromised microvascular
supply of oxygen secondary to the arteriolosclerotic changes
of aging. Vasospasm secondary to psychological stress may
further reduce perfusion in these diseased conditions, and
theoretically worsen RGC and axonal function which may
lead to premature apoptosis. Whether the ischemia itself and/
or reperfusion injury damages these structures is under
investigation [38].
Stress and hypothalamic–pituitary axis in glaucoma
Endogenous elevation of cortisol levels secondary to
chronic psychological stress may be damaging to the
trabecular outflow apparatus depending on the concentra-
tion and duration of this elevation. Human trabecular
meshwork cells contain glucocorticoid receptors [41, 42],
and would therefore be expected to respond to glucocorti-
coid administration. The exogenous administration of
glucocorticoids in man can generate a progressively
elevated intraocular pressure (IOP) which is dependent on
glucocorticoid potency, pharmacokinetics, duration of treat-
ment, route of administration as well as differences in
individual responsiveness [43]. Glucocorticoid-induced
ocular hypertension is due to increased aqueous humor
outflow resistance [43, 44]. Morphological examination of
the trabecular meshwork of patients with glucocorticoid-
induced glaucoma has shown an increased deposition of
extracellular material in the trabecular beams and in the
juxtacanalicular tissue, and a decrease in intratrabecular
spaces [43, 45]. With topical, periocular, intravitreal, or oral
administration of steroids for ocular inflammatory condi-
tions, patients may suffer from a steroid-induced intraocular
pressure elevation which may be severe and prolonged
enough to require filtering surgery of the eye to lower the
IOP. Jaffe et al. [46] studied the effects of intravitreal
fluocinolone acetonide implants (Retisert) for treatment of
uveitis. By week34 following implantation, 51.1% of
implanted eyes required ocular antihypertensive drops,
and 5.8% underwent glaucoma filtering surgery. During
this same period, the IOP of the fellow eyes did not rise
significantly. In August of 2008, safety labeling changes
were approved by FDA’s Center for Drug Evaluation and
Research (CDER). Based on clinical trials with Retisert,
CDER warned that approximately 77% of patients will
require IOP-lowering medications to control intraocular
pressure and 37% of patients will require filtering
procedures to control intraocular pressure within 3 years
post implantation. Endogenous cortisol elevation of Cush-
ing’s disease is known to be associated with ocular
hypertension [30]. At the Bascom Palmer Eye Institute,
an anecdotal case of an intraocular pressure spike in a
previously controlled glaucoma patient stricken by a severe
chronic psychological stressor has been observed. Pressure
elevation lasted for several weeks, and then returned to
baseline levels as the patient coped with and adjusted to the
stressor. The relationship between endogenous cortisol
elevation and intraocular pressure responses requires further
study.
Immune balance in glaucoma
Inflammatory mechanisms of glaucoma are being studied
by different investigators. Michal Schwartz has pioneered
the concept of harnessing the immune system to combat
neurodegenerative diseases including glaucoma [47]. Her
group has shown that immune deficiency or suppression
impair the recovery process after optic nerve crush, whereas
boosting a self-specific immune response, by both passive
and active immunization, promotes recovery. Those same T
cells that can lead to the development of autoimmune
disease can protect neurons under neurodegenerative con-
ditions, and it is a sub-population of regulatory T cells
which regulates the autoimmune response to promote
protection over injury. Dr. Schwartz’ team introduced the
concept of a therapeutic T-cell-mediated vaccination to
boost the immune response to facilitate neuroprotection in
glaucoma [48] .This immune defense involves lympho-
cytes, resident and infiltrating innate immune cells, the
microglia, and macrophages. The antigens of choice are
synthetic antigens, such as glatiramer acetate, that weakly
cross-react with self-antigens in the retina and optic nerves.
The vaccine induces a beneficial immune response that
recruits immune effector cells to counteract or neutralize
many of the compounds and factors that contribute to
ongoing destruction, and in addition supports cell renewal
and repair [49]. Working with Cohen et al. [50], Dr.
Schwartz has also published that maladaptation to mental
stress in mice was mitigated by the adaptive immune
system via depletion of naturally occurring regulatory
CD4+CD25+ cells. This begs the question of how
maladaptation to psychological stress may affect immune
balance in patients with glaucoma. A different team led by
Wax and Tezel has proposed that the inflammatory
cytokine TNF-α may be harmful to retinal ganglion cells
thereby having an etiologic role in glaucoma [51, 52].
While ischemic insults are implicated as the trigger for
TNF-α-mediated damage to the RGC, it is not known
what effect stress may have as an inciting factor.
When IOP is markedly elevated, clinicians often
inquire about the recent use of oral, topical, or injected
steroids. Clinicians may also consider inquiry regarding
potential life or environmental stressors in the context of a
previously well-controlled glaucoma patient who develops
a dramatic IOP increase or sudden deterioration of
function.
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An optimal ocular surface depends on the healthy interplay
of the immune system and neural circuitry. Inflammatory
mechanisms in the pathogenesis of keratoconjunctivitis
sicca have been well documented [53, 54]. The cornea is
provided with the richest innervation of all body tissues,
and it is generally accepted that corneal sensory innerva-
tion, via the ophthalmic division of the trigeminal nerve,
plays a key role in maintaining anatomical integrity and
function of the cornea and particularly of the epithelium
[55]. Experimental and clinical evidence suggests a
bidirectional control of corneal epithelium proliferation:
sensory neuromediators promote epithelial cell mitosis,
while, on the other hand, sympathetic mediators, epineph-
rine and norepinephrine, reduce epithelial cell mitosis [56].
In addition, in animal studies, corneal epithelial abnormal-
ities induced by lesioning of the sensory nerves can be
reduced by cervical sympathetic denervation [55, 57, 58].
Of similar interest is that Liu et al. recently published that
all five subtypes of muscarinic cholinergic receptors are
found on corneal and conjunctival cells, and these
muscarinic receptors have a role in epithelial cell prolifer-
ation similar to that of epithelial growth factor (EGF) [59].
Parasympathetic innervation of the lacrimal gland sponsors
proper secretory function, yet the relationship of dry eye to
psychological stress-induced autonomic dysregulation and
catecholamine excess has not been explored. In general,
chronic stress and sympathetic overdrive is linked to
parasympathetic inhibition. How parasympathetic imped-
ance affects lacrimal gland stimulation, muscarinic recep-
tors, and the ocular surface under conditions of
psychological stress requires further study.
Allergy, atopy, and uveitis
Based on the shifts from Th1 to Th2 immunity discussed
earlier, it is not surprising that clinicians may note
progression or exacerbation of allergic conditions with
aging and stress. The condition of atopic dermatitis
exemplifies the delicate balance between genetic, environ-
mental, and psychological factors in the evolution of the
dermal and, quite possibly, the ocular expression of the
disease. In a recent publication in Dermatologic Therapy,
Tausk et al. [11] describes that patients with atopic
dermatitis have an inherited deficiency in the HPA axis in
that they respond with a blunted production of cortisol in
response to experimental stressors. In addition, these
patients display an up-regulation of glucocorticoid recep-
tors on peripheral leukocytes, making them hyper-reactive
to steroid stimulation. The authors posit that, despite a
blunted HPA axis response to stress, effector cells that are
exquisitely sensitive to systemic glucocorticoid release may
respond in a hyper-reactive fashion to stress-induced
cortisol elevations, accentuating the cytokine shift from
the Th1 to the Th2 immune response. Pharmacologic doses
of corticosteroids are also able to suppress the production of
IL-4, which is a cytokine that mediates differentiation
towards Th2 cells, explaining the beneficial effects of
systemic or topical administration of these agents [11].
Ocular manifestations of atopic dermatitis in the form of
keratoconjunctivitis may also be likely to be exacerbated
under conditions of stress. Along similar lines, while no
known cause can be identified in the vast majority of cases
of acute anterior uveitis, clinicians who take a thorough social
history may discover that there is a predisposing stressful
eventtriggeringtheinflammatoryresponse.Ophthalmologists
and optometrists may inquire about potential psychological
and environmentalstressors when confronted with a patient in
the throes of an acute ocular presentation of these conditions.
Age-related macular degeneration
Age-related macular degeneration (AMD) is the leading
cause of legal blindness in persons age 65 years or older in
the USA. The prevalence of AMD increases dramatically
with age. A series of studies indicate the prevalence of dry
AMD to be as high as 15% by age 65 increasing to as much
as 30% by age 80. Advanced AMD affects more than
1.75 million individuals in the USA [60]. Owing to the
steady increase in life expectancy of the US population, this
number is expected to increase by 50% to almost 3 million
by 2020. Recent evidence strongly implicates immune
system activation of the alternative pathway of complement
in the pathogenesis of AMD [61]. Dry AMD may convert
to the wet form of advanced AMD, mediated by a cytokine
called vascular endothelial growth factor (VEGF) [62].
Lutgendorf et al. showed that elevated levels of vascular
endothelial growth factor were associated with lesser
degrees of social support in women with ovarian cancer
[63]. Lutgendorf’s findings raise the question of whether
similar imbalances may be at play in the immune-mediated
setting of age-related macular degeneration, a disease of the
elderly where a high incidence of anxiety has been reported
[64]. The relationship between stress and AMD onset and
progression is intriguing.
Ocular infection
A shift of Th1 to Th2 immunity with either aging or stress
may enhance susceptibility to viral infection. Clinically, it is
known that herpes simplex virus or herpes zoster virus
reactivation may occur in the face of psychological or
environmental stress. In addition, depression may have an
effect on innate immunity. In HIV-infected women, a study
by Evans et al. suggests that depression may decrease
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load [65]. In fact, a large epidemiology study found a
significant association between depression and HIV mor-
bidity and mortality in HIV-seropositive women. The
mortality rate was doubled in the women with chronic
depressive symptoms compared with women with limited
or no depressive symptoms [66]. Such alteration of innate
and adaptive immunity with negative psychological states
may also be associated with ocular infections such as
reactivation of ocular herpetic disease and toxoplasmosis,
and adenoviral keratoconjunctivitis. The latter seems
reasonable in view of the association of increased stress
with viral upper respiratory infection published in the
B r i t i s hC o m m o nC o l dS t u d y[ 15] and the Pittsburgh
Common Cold Study [16] mentioned earlier.
Ocular malignancy
The shift away from Th1 or cellular mediated immunity
with stress and aging may lead to onset of or progression of
malignancy. Chronic stress has been shown to alter the
diurnal cortisol curve with sustained elevation of cortisol
levels throughout the day and night to induce a flattening of
the diurnal cortisol slope. As shown by Sephton et al. [14],
this flattening of the cortisol rhythmicity has been shown to
predict shorter survival among women with metastatic
breast cancer. Lutgendorf has shown a significant relation-
ship between cortisol dysregulation, interleukin-6 (IL-6),
and vegetative depression in women with ovarian cancer
[28]. Parker et al. reported a model of stress-induced
carcinogenicity where UV-treated mice repeatedly exposed
to a predator scent developed squamous cell carcinomas
significantly earlier compared to non-stressed controls [67,
68]. Such negative outcomes spawn the question of whether
flattened cortisol curves (that is, chronically elevated
cortisol) may pose an increased risk for poor outcomes in
ocular malignancies such as melanoma and metastatic
carcinoma, and periocular malignancies such as squamous
cell, basal cell, sebaceous gland carcinoma, adenoid cystic
carcinoma, etc. in predisposed individuals.
Wound healing
Kiecolt-Glaser and colleagues investigated the quality of
marital relationships and the partners’ time to heal a dermal
blister wound. For those couples who engage in hostile
interactions, the median time to wound healing was 2 days
longer than for those couples who have non-hostile
interactions. (7 vs. 5 days) [69]. A study in older adults,
mean age 65, showed that exercise intervention with 30 min
of cardio exercise 3 days/week healed a 3.5 dermal wound
significantly faster than participants in a non-exercise group
(29.2 vs. 40 days, on average) [70]. Tausk draws the
conclusion that the process of wound healing is affected by
stressful life conditions, and states that this can be
improved through intervention or changes in lifestyle.
Before taking a patient to surgery, a line of questioning
about stress may shed light on events in the patient’s life
which may compromise their surgical result. Loss of a
loved one and divorce are particularly emotionally destabi-
lizing, and are associated with greater morbidity [6] and
mortality [13]. Postponement of the procedure to a more
favorable time would be optimal to facilitate timely wound
healing and prevent postoperative complications.
Spirituality acknowledged
While there is general agreement that religion and spiritu-
ality provide psychological comfort to patients, the physical
health benefits of spirituality, religion, and prayer remain
controversial due to a paucity of data from well-controlled,
methodologically sound investigations. Ironson [1] cites
major works which have reviewed hundreds of epidemio-
logic studies, and the conclusion was that there was
probable validity to an association between religion and
health, and that there may be a causal link. Patients may
identify themselves as spiritual but not religious, thus the
Ironson–Woods Spirituality/Religiousness Index is a mea-
sure that was developed to capture spirituality and
religiosity, and the private and public expression of both.
Evaluating four factors, a sense of peace, faith in God,
religious behavior, and a compassionate view of others,
Ironson et al. [1] used this measure to examine the relation
between spirituality and religiousness and important health
outcomes for people living with HIV, and to examine the
potential mediators of these relations. Long survival in
patients living with HIV was significantly related to the
frequency of prayer (positively), and negatively related to a
judgmental attitude. In addition, spirituality and religious-
ness yielded strong and significant correlations with less
distress, more hope, social support, health behaviors,
helping others, and lower cortisol levels. The relation
between religious behavior and health outcomes was not
due to social support. Upon further analysis, the authors
identified urinary cortisol concentrations and altruistic
behavior as mediators of the relation between spirituality,
religiousness, and long survival. A later study by Carrico et
al. [71] concluded that spirituality (using the Ironson–
Woods Spirituality/Religiousness Index) was associated
with higher positive reappraisal coping and greater benefit
finding, which, in turn, were both related to lower
depressive symptoms in 264 HIV-positive men and women
on highly active antiretroviral therapy. Furthermore, benefit
finding in this group was uniquely predictive of decreased
24-h urinary free cortisol output indicating lower stress
levels.
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dance of religious services has been shown to reduce
mortality. A review of well-controlled studies that exam-
ined the relationship between religiosity and health reported
the average reduction in risk of mortality in individuals who
frequently attend religious services to be approximately
30%; this drops to approximately 25% when adjusting for
potential confounding variables [72]. Hummer et al. [73]
found that weekly church/worship service attendance,
compared with less or no attendance, protected against the
onset of cardiovascular disease in a sample of 21,204 adults
followed for 8 years. Other large studies [74]h a v e
confirmed this finding. On the other hand, in a much
smaller cohort of only 503 patients, a study by Blumenthal
et al. [74] found little evidence that self-reported spiritual-
ity, frequency of church attendance, or frequency of prayer
is associated with cardiac morbidity or all-cause mortality
after acute myocardial infarction in patients with depression
and/or low perceived support. The authors mention that this
study used a restricted sample of patients who were
depressed and/or perceived themselves as having low social
support, and this may explain their failure to corroborate
the results of the other studies. Variations in population
characteristics and in spiritual measures may underlie the
controversy in published data relating spirituality to health
outcomes and mortality.
In 2004, Lutgendorf et al. [75] provided support for the
hypothesis that more frequent religious attendance in a
population-based sample of older adults is associated with
lower mortality and lower levels of interleukin-6 (IL-6), a
cytokine linked to a number of age-related diseases. These
findings were independent of potential confounding varia-
bles, such as age, sex, BMI, CRP, physical illness, social
network size, depression, and history of cardiovascular
disease, which were controlled in the structural equation
models. IL-6 levels are known to increase with chronic
stress and depression [76] and to decrease following
successful treatment of depression [77]. IL-6 promotes
angiogenesis in ovarian cancer and supports tumor growth
and metastatic spread [78]. Similar well-controlled studies
which explore the relationship of different facets of
spirituality and religiousness to the underlying immune
and neurobiological mechanisms of disease are necessary.
Conclusion
A multitude of studies over the years have attempted to
establish a relationship between psychological stress and
medical illness [33]. It is clear from the plethora of articles
in all fields of medicine that no organ system is protected
from the effects of negative emotional states. As a part of
the central nervous system, and privy to the alarmed cross-
talk of local hormones and neurotransmitters, one would
surmise that the eye would be particularly vulnerable to the
effects of psychological stress. It is surprising that vision
researchers have not embraced the approach of psychoneur-
oimmunology in addressing ocular disease.
Evidence suggests stress has a higher prevalence among
the elderly, and that anxiety disorders and phobias are more
common in the aged than the general population [64]. The
conditions which are most likely to induce chronic
debilitating stress are the emotional adjustments of retire-
ment, reduction in income, chronic illness, loss of mobility
or function, isolation from or loss of loved ones, divorce,
chronic strain such as caregiver’s stress, problems with
children, re-location, and many others. With increasing
clinic loads and less time spent with each patient,
ophthalmologists barely have enough time to conduct a
proper past medical history or review of systems, thus a
more intimate line of questioning regarding a patient’s
home life or emotional status is simply not undertaken.
Certain ocular conditions, as mentioned above, require that
physicians probe into the emotional status of their patients
to expose the underpinnings of the disease process and to
optimize the potential for recovery without recurrence.
Perhaps without realizing it, physicians minister the
spirit with a cheerful disposition, through addressing and
listening to their fears and concerns, with phrasing of
optimistic perspectives, and by the mere touch of a caring
hand upon a patient’s shoulder. Thus, the spirituality of
healing does not rest exclusively within the realm of the
patient. In contrast, a rushed physician may miss the
opportunity to establish this sacred and delicate relationship
with the patient through failure to explain or reassure in a
number of ways. During a busy clinic, this may often occur
without the physician’s awareness of having slighted the
patient. Particularly in the field of ophthalmology where
patients arrive for their visit frightened about the prospect of
debilitating visual loss or blindness, the good doctor will
tend not only their ocular condition but their emotional and
spiritual perspective regarding their ailment. It is helpful to
prioritize time with the patient to establish a compassionate
rapport which facilitates dialogue to assess these factors in
a gentle manner. Questions that address difficulty sleeping,
problems at work, tension in the home, irritability, worry,
and fear are necessary to know and understand a patient’s
inner struggle. Failure to do so compromises the individ-
ual’s opportunity for healing. As research lends more
support for the benefit of a spiritual approach to healing,
we may tap into a valuable therapeutic resource.
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